Practice Point®: Hematology | Podcast in RSS.com

Practice Point®: Hematology

Practice Point®: Hematology

di Practice Point Communications

Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse

Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse

Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse

Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 48 - Podcast: Making Sense of Immunotherapy Targets - Part 2 of RRMM Podcasts: Practical Insights for the First Relapse

Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 47 - Podcast: First Relapse Sets the Course - Part 1 of RRMM Podcasts: Practical Insights for the First Relapse

Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast

CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and additional under investigation, the therapeutic landscape continues to evolve rapidly. In this educational podcast, Dr. Joseph Mikhael highlights key advances in CAR T-cell therapy for MM. He reviews the most impactful data published or presented in 2025 and offers expert insight into how these emerging findings may shape current and future treatment strategies. Launch/Release Date: December 17, 2025 Activity Expiration Date: November 30, 2026 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO Professor, Clinical Genomics and Therapeutics Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer International Myeloma Foundation This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 45 - Clinical Clips® Crucial Advances in Hemophilia

A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint health and addressing patient needs/concerns. These include both replacement and novel non-replacement therapies. This activity is designed to update healthcare professionals with the latest cutting-edge evidence in hemophilia treatment that was presented during the annual hematology meeting in Orlando, FL. The Clinical Clips format will equip clinicians with the knowledge and confidence to integrate new evidence into personalized approaches, optimize patient outcomes, and improve the overall quality of care in hemophilia A and B. Launch/Release Date: December 12, 2025 Activity Expiration Date: November 30, 2026 FACULTY Angela Weyand, MD Associate Professor, Pediatrics University of Michigan Medical School Pediatric Medical Director University of Michigan HTC Co-Director, Hematology and Pediatric and Adolescent Gynecology Program Ann Arbor, Michigan This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast

Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed to delivering cutting-edge care. Through impactful presentations, posters and abstracts, Dr. Raajit Rampal provides expert commentary on the latest advances in Leukemia, Myelodysplastic Syndromes (MDS) and Myelofibrosis (MF) presented at the annual hematology meeting in Orlando, FL. Launch/Release Date: December 10, 2025 Activity Expiration Date: November 30, 2026 FACULTY Raajit Rampal, MD, PhD Director, Myeloproliferative Neoplasms Program Director, Center for Hematologic Malignancies Memorial Sloan Kettering Cancer Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices

In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into clinical practice and improve pediatric patient care. Launch Date: July 7, 2025 Release Date: July 7, 2025 Expiration Date: June 30, 2026 FACULTY Cindy Neunert, MD Division of Pediatric Hematology Oncology, and Stem Cell Transplantation Columbia University Irving Medical Center New York, New York This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

1 di 6